Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

People

Alexander L. Johnson

by Linda Wang
March 28, 2016 | A version of this story appeared in Volume 94, Issue 13

Alexander L. Johnson
[+]Enlarge
Credit: Courtesy of Joan Johnson
Photo of Alexander L. Johnson.
Credit: Courtesy of Joan Johnson

Johnson, 84, died on Nov. 16, 2015, in Lititz, Pa.

“Alex had a 30-year career in chemical research at DuPont and DuPont-Merck Pharmaceuticals at the Experimental Station in Wilmington, Del. His research involved a broad series of projects on exploratory heterocyclic medicinal and plant growth regulatory efforts. He was the group manager of the cardiovascular research team that discovered Cozaar (losartan), the first of a new class of blood-pressure-regulating drugs. Alex was also the author or coauthor of 105 publications, held 14 patents and was the speaker at numerous scientific meetings. He was an emeritus member of the American Chemical Society and a fellow of the New Zealand Institute of Chemistry.”—Joan E. Johnson, wife

Most recent title: associate director of research, DuPont-Merck Pharmaceuticals

Education: B.Sc. and M.Sc., chemistry, 1953 and 1954, Victoria University of Wellington; Ph.D., chemistry, 1964, University of Rochester

Survivors: wife, Joan; daughters, Victoria and Alexandra; son, Christian; and five grandchildren

To recognize your late loved one or colleague, submit obituary information at cenm.ag/obits.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.